Marsh & McLennan’s MMC global management consulting unit Oliver Wyman along with the market-leading risk management platform, Corridor Platforms, recently announced a strategic partnership to offer banks and non-bank financial institutions solutions and help update and digitize credit extension, transactions and end-to-end risk management.
The tie-up will combine Corridor Platforms’ unique, modular and cloud-based risk management platform that assists in credit modeling, loan valuation and real-time policy execution with Oliver Wyman’s competence in risk management, such as next-generation risk analytics, model development and data or process management.
Armed with rich experience in risk analytics, Oliver Wyman expects to convince its clients for adopting advanced processes and technology.
Notably, Corridor is the perfect partner for this strategic move as it has first-hand experience in this area and also launched an integrated solution that allows companies to take a step forward in the direction of state-of-the-art analytics in risk and more.
This new platform would easily boost the efficiency and capability of decision-making across the customer lifecycle, allowing clients to unveil real business advantages from their investments in big data and analytics. The solution will cater to customers in a way that they can fully utilize their assets and existing capabilities and at the same time integrate with the fast-emerging open source technologies.
There are many solutions out there that help extract new data sources and enable experimentation with the machine learning-based models but this Corridor Platforms service works on how to assimilate the same with internal advancements in current systems.
Marsh & McLennan has always been active when it comes to alliances and acquisitions in order to enter new geographies, expand within the existing ones, foray into new businesses, develop new segments and specialize within its prevalent operations.
Strategic collaborations also drive the capability of the company’s peers, such as Aon plc AON, and allow it to evolve as one of the largest insurance brokers. Brown & Brown Inc.’s BRO impressive growth is also attributable to organic and inorganic means across all segments.
Shares of this Zacks Rank #3 (Hold) company have rallied 20.2% in a year’s time, underperforming its industry’s growth of 34.2%.
Investors interested in the same space might take a look into a better-ranked stock like eHealth, Inc. EHTH. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
eHealth offers private health insurance exchange services to individuals, families and small businesses in the United States and China. The company currently carries a Zacks Rank #2 (Buy). It delivered a beat in three of the last four quarters, the average positive surprise being 127.73%.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Brown & Brown, Inc. (BRO) : Free Stock Analysis Report
eHealth, Inc. (EHTH) : Free Stock Analysis Report
Marsh & McLennan Companies, Inc. (MMC) : Free Stock Analysis Report
Aon plc (AON) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research